| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.78 | 0.003 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |